CYP19A1 and obesity disorder: Insulin resistance, breast adipose inflammation, the increased expression of aromatase enzyme, elevated leptin, and the inflammation of breast adipose tissue have all been attributed to obesity-associated post-menopausal breast cancer [57,82].